I
nduction of an inflammatory reaction occurs when healthy tissues are traumatized or infected by microbial pathogens (1, 2) . The inflammatory response is initially characterized by recruitment and accumulation of phagocytic effector cells, mainly neutrophil granulocytes and monocytes, in the affected tissue. At the inflamed site, the primary functions of these cells are to kill invading microbes, clear the tissue of debris, and initiate the resolution phase (1) . Although inflammation is vital in tissue repair and eradication of pathogens, an unresolved inflammatory response and inappropriate cellular activation can be detrimental to the host (3) . Knowing the precise mechanisms underlying phagocyte function under normal healthy conditions is thus fundamental and crucial for our understanding of pathological immune reactivity in disease.
The inflammatory response is normally initiated and maintained and sometimes modulated by a number of microbial or host-derived pathogen-and danger-associated molecular patterns (PAMPs and DAMPs) (4) (5) (6) , and it is clear that these DAMPs and PAMPs together participate in a multistep hierarchy of directional cues that regulate neutrophil function at inflammatory sites (7, 8) . Formyl peptides, hallmarks of bacterial protein synthesis (9) , exert their functions through pattern recognition receptors (PRRs) known as the formyl peptide receptors (FPRs), a group of receptors that belong to the family of G-protein-coupled receptors (GPCRs). The FPRs are expressed primarily in inflammatory or innate immune cells such as neutrophils (expressing FPR1 and FPR2) and monocytes (expressing also FPR3 [10] [11] [12] ). Shortchain fatty acids (SCFAs) are also produced by bacteria and reach very high concentration in the gut, where they constitute another type of microbial pattern (13) . The SCFAs are subsequently transported over the gut epithelium to be released in the bloodstream, where they may reach millimolar concentrations. The SCFAs have been shown to activate leukocytes, and two until fairly recently orphan receptors, GPR41 and GPR43 (now known as free fatty acid receptor 3R [FFA3R] and FFA2R, respectively), have been identified as fatty acid-recognizing receptors (14) . These two receptors also belong to the family of GPCRs, and one of these, FFA2R, is highly expressed in neutrophils; published data suggest that the receptor has important roles in orchestration of inflammatory reactions (15) , and on that basis, it is of interest as a drug target (16) . A proper and defined regulatory role for FFA2R in neutrophil function has not been possible to disclose, due to the lack of potent and selective agonists and antagonists. Given the fact that novel selective ligands, both orthosteric FFA2R agonists and antagonists, were recently described (17, 18) , this situation is now about to change.
We have determined the basic activation and inhibition properties in relation to human neutrophils of Cmp1 and CATPB (see below), two recently described FFA2R ligands (17, 18) . The new FFA2R ligands were initially characterized through the desensitization and inhibition profiles of the neutrophil response (transient increase in cytosolic Ca 2ϩ ) to acetate, and we show that Cmp1 is a selective FFA2R agonist and CATPB is a potent antagonist for the same neutrophil receptor. The potency of Cmp1 to induce reactive oxygen species (ROS) production in naive neutrophils was low, but the production was significantly increased in cells first primed with tumor necrosis factor alpha (TNF-␣) or latrunculin A. We also show that neutrophils isolated from an aseptic inflammation are nonresponders to Cmp1, suggesting a role for FFA2R in the recruitment process. The FFA2R agonist Cmp1 [3-benzyl-4-(cyclopropyl-(4-(2,5-dichlorophenyl)thiazol-2-yl)amino)-4-oxobutanoic acid] and the antagonist CATPB [(S)-3-(2-(3-chlorophenyl)acetamido)-4-(4-(trifluoromethyl)phenyl) butanoic acid] were synthesized as described previously (17, 19, 20) .
MATERIALS AND METHODS

Chemicals
The FPR2-specific hexapeptide WKYMVM and the FPR1-specific peptides fMLF and fMIFL were synthesized and high-performance liquid chromatography (HPLC) purified by TAG Copenhagen A/S (Copenhagen, Denmark). The two formylated peptides are full FPR1 agonists that can be used interchangeably as control agonists specific for this receptor; the 50% effective concentrations (EC 50 s) in our neutrophil NADPH oxidase assay system (see below) were 1 and 50 nM for fMIFL and fMLF, respectively (21, 22) . Neutrophil isolation from blood and tissue. Blood neutrophils were isolated from heparinized whole blood or buffy coats from healthy blood donors by dextran sedimentation and Ficoll-Paque gradient centrifugation as described by Bøyum et al. (23) . Remaining erythrocytes were removed by hypotonic lysis, and the neutrophils were washed twice and resuspended in KRG and stored on ice until use.
In vivo-transmigrated neutrophils were obtained from skin chambers; details on the methodology are given in reference 24. Briefly, blisters were formed on the forearms of healthy volunteers by negative pressure for 2 h. The blister roofs were removed, and autologous serum was added to collection chambers that were sealed and left for 24 h. The chamber fluid containing neutrophils was then collected, and the cells were pelleted and stored in KRG on ice until use. Blood neutrophils were isolated from the same subjects on the day of collection.
Measuring NADPH oxidase activity. Isoluminol-enhanced chemiluminescence (CL) was used to measure superoxide production, the precursor of production of reactive oxygen species (ROS), by the NADPH oxidase activity as described previously (25, 26) . In short, the CL measurements were performed in a six-channel Biolumat LB 9505 (Berthold Co., Wildbad, Germany), using disposable 4-ml polypropylene tubes and a 900-l reaction mixture containing 10 5 cells, isoluminol (2 ϫ 10 Ϫ5 M), and HRP (4 U). The tubes were equilibrated for 5 min at 37°C before addition of an agonist (100 l), and the light emission was recorded continuously. To study desensitization and reactivation of a receptor, naive (nondesensitized) cells were stimulated with the receptor-specific agonist and when the response triggered was terminated (usually in 5 to 10 min), a new agonist binding to the same receptor (desensitization) or actin-disrupting agent latrunculin A (reactivation) was added. In experiments in which the effects of receptor-specific antagonists were determined, these were added to the reaction mixture 1 to 5 min before stimulation. Control cells incubated under the same condition but receiving no antagonist were used in parallel.
Calcium mobilization. Neutrophils at a density of 1 ϫ 10 6 to 3 ϫ 10 6 /ml were washed with Ca 2ϩ -free KRG and centrifuged at 220 ϫ g. The cell pellets were resuspended at a density of 2 ϫ 10 7 cells/ml in KRG containing 0.1% bovine serum albumin (BSA) and loaded with 2 M Fura-2-AM for 30 min at room temperature. The cells were then diluted to twice the original volume with RPMI 1640 culture medium without phenol red (PAA Laboratories GmbH, Pasching, Austria) and centrifuged. Finally, the cells were washed once with KRG and resuspended in the same buffer at a density of 2 ϫ 10 7 /ml. Calcium measurements were carried out in a PerkinElmer fluorescence spectrophotometer (LC50), with excitation wavelengths of 340 nm and 380 nm, an emission wavelength of 509 nm, and slit widths of 5 nm and 10 nm, respectively. The transient rise in intracellular calcium is presented as the ratio of fluorescence intensities (340 nm to 380 nm) detected.
A change in intracellular Ca 2ϩ was also measured using flow cytometry with mixed leukocytes as described previously (27) . In short, mixed leukocyte populations were loaded with the Ca 2ϩ indicator dyes Fluo-3 (Molecular Probes; fluorescence increases upon Ca 2ϩ binding) and FuraRed (Molecular Probes; fluorescence decreases upon Ca 2ϩ binding). Fluo-3 and FuraRed intensity was recorded continuously using an Accuri C6 flow cytometer (BD Accuri), and stimuli were added as indicated below. Analysis was performed using FlowJo software (v. 7.6.5; TreeStar), and results are presented as the ratio between Fluo-3 and FuraRed (normalized against the value at time zero), reflecting the relative cytosolic Ca 2ϩ concentration, over time.
Cell surface receptor expression. The level of surface expression of the integrin complement receptor 3 (CR3) was determined by the use of a phycoerythrin (PE)-conjugated antibody against CR3 (BD Biosciences, MD). To surface label the polymorphonuclear leukocytes (PMNs), cells in KRG (5 ϫ 10 6 /ml) were incubated on ice, the antibodies were added, and the incubation was prolonged for 30 min. Control samples incubated with isotype control antibodies were included. After a washing step to remove excess unbound antibodies, the amount of bound fluorescence was determined by flow cytometry using an Accuri C6 flow cytometer (Becton Dickinson, Sparks, MD).
Chemotaxis assay. Neutrophil migration was determined using a 96-well microplate chemotaxis chambers with hydrophobic filters with a pore size of 3 m (ChemoTx; Neuro Probe Inc., Gaithersburg, MD) according to the instructions given by the manufacturer. In short, Cmp1 at various concentrations was added to wells in the lower chamber. All dilutions were made in KRG supplemented with 0.3% BSA. Naive or TNF-␣-primed neutrophils (30 l; 10 6 /ml) were placed on top of the filters and allowed to migrate for 90 min at 37°C. Cell migration was examined under a microscope. For quantification, the content of myeloperoxidase was assessed in the lysates of transmigrated cells by adding the peroxidase substrate o-phenylenediamine.
Data collection and statistical analysis. Data were collected from individual blood donors and processed using GraphPad Prism. One-way analysis of variance (ANOVA) was used for statistical analysis. Significant differences are indicated in the figures.
RESULTS
Cmp1 activates the phospholipase C-inositol phosphate 3 (IP 3 )-Ca
2؉ signaling route in neutrophils and desensitizes the cells to acetate. A molecule identified from the patent literature with reported activity on free fatty acid receptor 2 (FFAR2) was recently characterized as an orthosteric agonist for the human FFAR2/ GPR43 (17) , and this compound, Cmp1 (structure shown in Fig.  1A ), was used to investigate the basic functions of this receptor in human neutrophils. FFA2R belongs to the family of G-proteincoupled receptors (GPCRs), and one of the very early signals generated by many GPCR agonists in neutrophils is a rise in the cytosolic concentration of free Ca 2ϩ ([Ca 2ϩ ] i ). Accordingly, naive neutrophils responded dose dependently by transient increases in [Ca 2ϩ ] i to both Cmp1 ( Fig. 2A ) and to one of the known natural agonists for FFA2R, acetate (Fig. 2B ). As expected, Cmp1 was much more potent than acetate (EC 50 s of 640 nM for Cmp1 and 2 mM for acetate [ Fig. 2C] ). Neutrophils activated with Cmp1 were homologously desensitized in their response to acetate, and the desensitization protocol worked also when the order of the FFA2R agonists was reversed; i.e., neutrophils desensitized to acetate were nonresponsive to Cmp1 (Fig. 3A) . The Cmp1-desensitized cells were fully responsive to the formylated peptide fMIFL, a prototype agonist for one of the formyl peptide receptors (FPR1) expressed in neutrophils (Fig. 3B) .
The very rapid rise in the cytosolic concentration of free [Ca 2ϩ ] i induced in neutrophils is for many GPCR agonists achieved through an emptying of intracellular Ca 2ϩ stores. A rise in [Ca 2ϩ ] i originating from the stores should be largely insensitive to the presence of EGTA, which chelates all extracellular free Ca Cmp1 and also by acetate were basically left unchanged in the presence of EGTA (Fig. 3C) .
Most GPCRs present in neutrophils are expressed also in monocytes, and to determine if this was valid also for a functional FFA2R, the Cmp1-induced rise in [Ca 2ϩ ] i was determined in a mixed leukocyte preparation. In agreement with the results described above, neutrophils responded to Cmp1 by transient increases in [Ca 2ϩ ] i , but no such change was induced in monocytes or lymphocytes (Fig. 4) . The response induced in neutrophils and monocytes by the FPR1-specific agonist fMLF is shown for comparison (Fig. 4) . The monocytes remained nonresponders to Cmp1 also in cells that were first primed with TNF-␣ (see Fig. S1 in the supplemental material).
The novel FFA2R antagonist CATPB inhibits the transient rise in intracellular Ca 2؉ induced in neutrophils by acetate or Cmp1. In addition to a potent agonist, a selective inhibitor for FFA2R would be equally useful in defining the basic functions triggered through this receptor, and one such antagonist, or rather, inverse agonist, CATPB (structure shown in Fig. 1B) , has been described previously (20) . This novel inhibitor, selective for the human FFA2R, was used to further characterize receptor-specific events. No direct [Ca 2ϩ ] i change was induced in neutrophils by CATPB alone, but the presence of CATPB dose dependently inhibited the transient increase in [Ca 2ϩ ] i induced by Cmp1 (Fig.  5A) or acetate (Fig. 5B ). In addition, there was no effect of CATPB on the response induced by the FPR1 agonist fMLF (Fig. 5C ), and likewise, there was no effect of the FPR1-selective antagonist (cyclosporin H) on the Cmp1-induced neutrophil response (see Fig.  S2A in the supplemental material). The inhibitor/inverse agonist was fairly potent, as full inhibition of the Cmp1-induced response was achieved with a molar ratio of 0.1 between the inhibitor CATPB and the Cmp1 agonist (Fig. 5A) .
Taken together, these data show that Cmp1 is a potent FFA2R agonist and CATPB is a potent and selective inhibitor/antagonist for the same receptor.
A low degree of mobilization of neutrophil secretory organelles and no chemotaxis were induced by Cmp1. Cmp1 at 1 M induced a maximal rise in [Ca 2ϩ ] i , but this concentration triggered a fairly low level of granule secretion as measured by an increased exposure of complement receptor 3 (CR3), a receptor stored in easily mobilized neutrophil organelles (Fig. 6A) . In addition, Cmp1 was unable to cleave the neutrophil activation marker L-selectin from the cell surface (Fig. 6B) . In contrast, Lselectin was cleaved off from the cell surface of the positive-control cells treated with TNF-␣, and surface CR3 was also upregulated by the cytokine (Fig. 6A and B) . Taken together, the results show that Cmp1, like most neutrophil chemoattractant GPCR agonists, induces a rise in [Ca 2ϩ ] i , but despite this it is not a potent secretagogue. In addition, the chemotactic activity of Cmp1 was examined (Fig. 6C ). We used a classic Boyden filter technique but could not detect any increased migration over the buffer control values when Cmp1 was present in the lower compartment of the chambers (Fig. 6C) . The neutrophils remained nonresponders to ] i increase given by the ratio between Fura-2 fluorescence at 340 and 380 nm; the bar represents a ratio value of 1.0. (C) Neutrophils loaded with Fura-2 were stimulated with Cmp1 (1 M), acetate (10 mM), or fMFL (10 nM) in the absence or presence of CATPB (500 nM). The rise in intracellular Ca 2ϩ was determined, and the peak activities were determined (mean Ϯ SEM; n ϭ 3). ****, P Ͻ 0.0001; ns, no significance.
Cmp1 in the chemotaxis assay also when cells were first primed with TNF-␣ (see Fig. S3 in the supplemental material).
TNF-␣ primed the Cmp1-triggered activation of the neutrophil NADPH oxidase. Neutrophils are equipped with an enzyme system that at the expense of NADPH reduces molecular oxygen to superoxide, and when activated, this system gives rise to a mitochondrion-independent respiratory burst (28). Classical neutrophil chemoattractants activate the neutrophil NADPH oxidase, and reactive oxygen metabolites are secreted (29) . The two FFA2R ligands were used to determine the relation between this receptor and the neutrophil superoxide-generating oxidase. We show that also the FFA2R agonist Cmp1 activates the NADPH oxidase to produce superoxide and the activity was concentration dependent, with an EC 50 of 1 to 2 M and a maximum response obtained with around a 5 M concentration of the agonist (Fig. 7A) . The time course of the response induced was very similar to that induced by the FPR1 agonist fMIFL (a rapid onset and a peak of the activity reached after around 45 s [Fig. 7A, inset] ), but the efficacy of Cmp1 was low compared to that of the FPR1 agonist (peak ratio value fMIFL/Cmp1 Ϸ 10 [ Fig. 7A and inset] ).
No NADPH oxidase assembly and activation was obtained when neutrophils in suspension were challenged with TNF-␣, and this is in agreement with results reported earlier (30) (31) (32) . However, TNF-␣ primed the neutrophils in their response to fMIFL (an FPR1 agonist) (Fig. 7B, inset) , WKYMVM (an FPR2 agonist), PAF (an agonist for the PAFR) (31, 33), and Cmp1. As recorded by an increased release of superoxide, Cmp1 was turned into a potent activator of the NADPH-oxidase in TNF-␣-primed neutrophils (Fig. 7B) .
TNF-␣ induces a mobilization of receptor-storing granules without any transient increase in [Ca 2؉ ] i . As shown in Fig. 7B , neutrophils were primed in their response to Cmp1 by the cytokine TNF-␣, the primed neutrophils produced at least 5 times (measured as peak values) more superoxide anions than did naive neutrophils, and the production reached levels comparable to that induced by fMLF. Previous studies have shown that many neutrophil receptors, including FPR1 and FPR2, are stored in secretory organelles of naive cells (34) (35) (36) , and mobilization of FPRs to the cell surface is accompanied with a primed FPR response, suggesting a possible role for granule mobilization in mediating priming.
We show that neutrophils treated with TNF-␣ exposed an increased number of the CR3 (Fig. 6A); i.e., integrin-storing organelles have been mobilized, and thus, receptor mobilization could serve to explain the increased oxidative response in primed cells. Marker analyses of secreted material suggest that TNF-␣ is a secretagogue both for the gelatinase granules (marker MMP9) and, to some extent, for the specific granules (marker NGAL). No release of MPO, a marker for the azurophil granules, was obtained (Fig. 8A ).
An increase in [Ca 2ϩ ] i alone is sufficient to trigger fusion be- tween neutrophil receptor-storing organelles and the plasma membrane (37) . The nexus between TNF-␣-triggered responses and the role of a transient cytosolic calcium increase has, however, not been finally settled, as the cytokine has been shown to induce different types of intracellular calcium responses in surface-adherent neutrophils and cells in suspension (38) (39) (40) (41) . We found that the TNF-␣-triggered mobilization of granule constituents in neutrophil suspensions occurred without any transient increase in [Ca 2ϩ ] i (Fig. 8B ). For comparison, we show the response induced by the chemoattractant fMLF that induces a transient rise in intracellular calcium (Fig. 8B) .
Cmp1-induced NADPH oxidase activity was inhibited by pertussis toxin and by the FFAR2 antagonist CATPB. To determine the sensitivity of FFA2R to pertussis toxin, neutrophils were treated with the toxin, samples were removed after different durations of incubation, and the ability of the cells to generate O 2 Ϫ was determined when cells were challenged with Cmp1, fMIFL, or a direct protein kinase C (PKC) activator (phorbol myristate acetate [PMA] ) that bypasses heterotrimeric G proteins. The ability of the cells to respond to Cmp1 and fMIFL was gradually lost, and after a 120-to 250-min incubation with pertussis toxin, the neutrophils were unresponsive to these agonists (shown for Cmp1 in Fig. 9A ), whereas only a small reduction was seen in the response to PMA (Fig. 9A, inset) .
Taken together, our data show that the neutrophil receptor used by Cmp1 to activate the neutrophil NADPH oxidase is FFA2R, and the signals generated are transferred by an activation of G␣ i . The FFA2R antagonist CATPB by itself triggered no activation of the neutrophil NADPH oxidase, but the oxidase activities induced by Cmp1 in both naive (Fig. 9B, inset) and latrunculin A-primed cells (see below) were largely inhibited by the antagonist (Fig. 9B and C) . CATPB inhibited also the response induced by Cmp1 in TNF-␣-primed neutrophils (Fig. 9C) . In agreement with the inhibition profile of the different receptor antagonists on the rise in [Ca 2ϩ ] i (see above), CATPB inhibited the Cmp1-induced response, whereas there was no effect on the response triggered by an FPR agonist. In addition, there were no effects of the specific FPR antagonist (CysH for FPR1) on the Cmp1-induced response (see Fig. S4 in the supplemental material). Similar to results obtained when monitoring [Ca 2ϩ ] i , CATPB was a very potent inhibitor in that the Cmp1-induced neutrophil activity was inhibited when the two were presented in a molar ratio (CATPB/Cmp1) of around 0.1.
The Cmp1 molecule was replaced by acetate, and the results obtained were basically the same, but the activity induced by the short-chain fatty acid was of a lower magnitude and millimolar concentrations were required for activation, with an EC 50 for activation of around 5 mM.
Termination of the FFA2R-triggered response and role of the cytoskeleton. It is well established that neutrophils generate and secrete reactive oxygen species in response to many inflammatory mediators that bind to receptors, such as the FPRs and C5aR, and that this response is substantially increased and also prolonged when agonist binding takes place in the presence of drugs which inhibit actin polymerization (i.e., cytochalasin B or latrunculin A) and by that disrupts the cytoskeleton. Accordingly, the response induced by fMIFL was both prolonged and increased in neutrophils pretreated with latrunculin A (Fig. 10A) , and a comparison of the maximal responses reveals a ratio between peak values in the presence and absence of latrunculin A, respectively, of 3 to 4. When investigating the effect of latrunculin A as a priming agent on the response induced in neutrophils activated with Cmp1 (Fig.  10B) , it is clear that the effect was more dramatic and in the presence of the cytoskeleton-disrupting drug Cmp1 became very potent in activating the NADPH oxidase. The level of superoxide production induced by Cmp1 reached the same level as that triggered by an FPR1 agonist (Fig. 11) , and the ratio between the peak values in the presence and absence of latrunculin A was around 50 (Fig. 10B) .
As mentioned, the response in neutrophils induced by FPR1 agonists measured as NADPH oxidase activity is very much prolonged in the presence of latrunculin A (Fig. 10A) , suggesting a role for an intact cytoskeleton in the termination of the response induced by the FPR1 agonist. The kinetics of the Cmp1-induced activity in latrunculin A-treated neutrophils is very similar to that induced by the FPR1 agonist in the absence of the drug. This suggests that the responses induced by the two receptors are terminated by different mechanisms. Earlier studies have shown that the agonist-occupied FPR1 rapidly becomes desensitized, and this is achieved through a binding of the receptor-ligand complex to the cytoskeleton, a process that leads to a lateral segregation of the occupied receptor from the signaling heterotrimeric G-protein. Accordingly, the prolongation of the FPR1-induced response in the presence of cytoskeleton-disrupting drugs is due to an inability of the disrupted cytoskeleton to bind the receptor-ligand complex and terminate signaling. Neutrophils activated with FPR agonists become after a short period of active signaling (measured as superoxide production) desensitized to a new dose of the same attractant (42) , but the desensitized FPR1 is reactivated by latrunculin A, as shown by the robust burst of oxidase activity induced in desensitized cells when the cytoskeleton is disrupted (Fig. 10C) . This response is triggered through FPR1, which is clear from the fact that cyclosporin H totally inhibits the activity (43) . We have now determined the effect of latrunculin A as a receptor uncoupler on cells desensitized to Cmp1. A very low level of NADPH oxidase activity was induced in these cells when latrunculin A was added (Fig. 10C) , but the cells were fully responsive to an FPR1 agonist (see Fig. S5A in the supplemental material) . The time window in relation to Cmp1 addition between achieving full activity and no activity upon addition of latrunculin A is fairly narrow; addition of latrunculin A 1 min prior to the addition of Cmp1 is sufficient to obtain full receptor activity, whereas a gradually lower activity is obtained when latrunculin A is added at later time points (see Fig. S5B ). In contrast, the desensitized FPR1 is fully reactivated also when latrunculin A is added 20 min after the agonist.
Skin chamber neutrophils are low responders to Cmp1. In vivo-transmigrated neutrophils were obtained from skin chambers, allowing us to determine to what extent a modulation of the response to Cmp1 occurs during the recruitment process in vivo.
The process of migration from blood to tissue renders neutrophils primed in their response to some agonists and desensitized to others (24) . The skin chamber neutrophils migrate toward an aseptic, acute inflammation in an otherwise healthy tissue, and a primed response achieved through extravasation may be a regulatory mechanism, granting a cellular response (such as release of toxic oxygen radicals) only at sites where it is functional and necessary, e.g., in inflamed or infected areas, but indicates also that natural agonists for such a receptor are not used as attractants. We now confirm earlier findings (24) by showing that the response induced in skin chamber neutrophils by an FPR1 agonist was primed (shown with fMIFL in Fig. 11A ), but in contrast to this, we show that the response induced in in vivo-transmigrated neutrophils by Cmp1 was largely attenuated (shown with latrunculin A-treated cells in Fig. 11B ).
DISCUSSION
There has been an urgent need for synthetic receptor-specific ligands to allow studies of FFA2R in neutrophils. The recently described Cmp1 and CATPB molecules fulfill the requirements in being both fairly potent and receptor selective (17, 20) . The expression and basic functional characteristics of FFA2R in phagocytic cells were described when the receptor was deorphanized and shown to be predominantly expressed in peripheral blood leukocytes and recognize short-chain free fatty acids (44, 45) . Using Cmp1, we now confirm some of the original findings stating that the agonist occupied FFA2Rs activate neutrophils through a signaling cascade that involves a pertussis toxin-sensitive G-protein and the IP 3 route to induce a release of Ca 2ϩ from intracellular storage organelles, responses similar to the characteristics of the fairly well-characterized receptor for formylated methionyl containing peptides (FPR1). We also add some new molecular insights into regulatory mechanisms of FFA2R activation and termination and disclose both similarities to and differences from the FPRs. It is clear that although Cmp1 induces a rise in intracellular Ca 2ϩ in neutrophils, this response is not accompanied by any mobilization of CR3 to the cell surface or cleavage of L-selectin from the cell surface. The main storage pool for the ␤ 2 -integrin CR3 is the easily mobilized secretory granules, the most readily mobilized neutrophil vesicles/granules (37) . The increased exposure of CR3 together with the shedding of L-selectin are the two most sensitive neutrophil markers for activation, a process that constitutes the basis for how neutrophils grade their response to chemoattractants and allow them to leave the bloodstream and enter an inflamed tissue. In agreement with the low degree of neutrophil activation induced by FFA2R agonist, no chemotactic activity was induced by Cmp1.
Activation of neutrophils with the FFA2R agonist Cmp1 induced an assembly of the superoxide-generating NADPH oxidase. The degree of activation was, however, fairly low, but TNF-␣ pronouncedly primed the response. Although extensively studied, the precise mechanism underlying priming of the NADPH oxidase response has not been clarified. The fact that pretreatment with TNF-␣ induced mobilization of neutrophil organelles suggests a role for this process in priming (35, 46) , and it is clear that the priming effect of TNF-␣ is evident also with other stimuli, for which a mobilization of receptor-storing organelles might be part of the priming mechanism (35, 47) . It has also been suggested that the profiles of the neutrophil subcellular proteome may be used as a base to predict the subcellular localization of different protein, but despite the fact neutrophils express functional receptors, for example, for TNF-␣ and FFA2R, these receptors do not show up in such a subcellular proteome (48) . Moreover, the receptor for the lipid chemoattractant PAF is expressed exclusively in the plasma membrane (33) , and despite this, TNF-␣ also primes the PAF-induced neutrophil response (33) . Priming may thus be achieved without receptor mobilization; additional suggested mechanisms include increased membrane expression or translocation of NADPH oxidase components (49) , alterations of intracellular signaling pathways, increased protein phosphorylation (50) , phospholipase activity (51), intracellular Ca 2ϩ changes (52), cross talk between Ca 2ϩ increase and tyrosine phosphorylation (53) , altered assembly of the oxidase (54) , and proteolytic processing of cell surface proteins (55) . Multiple mechanisms may be involved in TNF-␣-induced priming, and since no antibody is available that recognizes surface-expressed FFA2Rs, it is not possible to conclusively determine the degree of mobilization of the FFA2R during priming. Although the precise mechanism is unknown, it is interesting to note that TNF-␣ recruits receptors from easily mobilizable granules/vesicles to the neutrophil cell surface without any transient rise in intracellular calcium, whereas Cmp1 The neutrophil response was measured as superoxide production that was recorded continuously. The peak activities were determined, and the results are expressed as percent activity remaining in the presence of the antagonist compared to the value for control neutrophils without any antagonist (mean Ϯ SEM; n ϭ 3). ****, P Ͻ 0.0001. is a weak secretagogue despite its capacity to induce a transient rise in [Ca 2ϩ ] i . These data raise questions that we at present only can speculate upon, and these include the mechanisms for priming of the FFA2R mediated response by TNF-␣ and the precise role of calcium in granule mobilization.
It is clear that the easily mobilized neutrophil organelles and their content of adhesion molecules and receptors are of outmost importance for the extravasation process that recruits neutrophils from the bloodstream to inflamed or infected tissues (56) , where they exert their function in vivo. The precise role of FFA2R in the recruitment process remains to be determined, but during this process, the cells mobilize their granules/vesicles to expose new receptors on the cell surface, meaning that the exudated cells are subsequently transferred to a primed state in their response to receptor agonists not directly involved in the extravasation process. In contrast, exudated neutrophils are attenuated in their response to agonists thought to be involved in the recruitment (i.e., the C5aR and the interleukin 8 receptor [IL-8R]) (47, 57, 58) . The functional role of FFA2R activation in inflammatory reactions is unclear, but many danger signals attract neutrophils to sites of infection. In accordance with this, reduced accumulation of neutrophils has been described to characterize the anti-infective response in FFA2R-deficient animals, and at the same time such a deficiency protects inflamed tissues from destruction (59) . The basic characterization of Cmp1 as a neutrophil-activating agonist was conducted on cells isolated from peripheral blood, but it is clear that tissue neutrophils, obtained by a skin chamber technique, behave differently in that these cells were nonresponders to the FFA2R agonist. We know from earlier studies that the transmigrated neutrophils have partly mobilized their intracellular granules and the cells express increased or decreased expression levels of functional receptors depending on whether the receptors are present in the granules and recruited from the stores but also on the specific roles of the receptors in the recruitment process. The receptors belonging to the FPR family are upregulated on exudated neutrophils, whereas CXCR1/2, the PAFR, and the C5aR are downregulated (58) . The direct involvement of FFA2R in neutrophil recruitment to inflammatory sites has been shown in intestinal inflammation in which the receptor agonists are supposed to have microbial origin, and in accordance with this, FFA2R knockout mice exhibit diminished inflammation in bowel disease models, suggesting that the receptor is involved in the recruitment process. We now add FFA2R to the group of receptors with attenuated responses in neutrophils recruited to an aseptic inflammation, but we do not know whether the lack of a Cmp1 response in tissue neutrophils means that the receptor is directly involved in the recruitment process also in nonmicrobially related inflammation or if it is an effect of a heterologous receptor desensitization process mediated by another receptor that is higher in the hierarchy than FFA2R.
It is well established that signaling through GPCRs typically starts with a conformational change of the ligand-occupied receptor and after a period of signaling, the activities are terminated and the occupied receptor becomes refractory to further stimulation with the same agonist, a process commonly termed homologous desensitization (60, 61) . One of the mechanisms suggested to induce such a desensitization is receptor phosphorylation. The currently generally accepted model for termination of GPCR signaling is the binding to occupied receptors of ␤-arrestin, and this binding is suggested to mediate homologous desensitization and signaling termination (62) . The formation of such a receptor-arrestin complex affects the G-protein binding interface of the receptor, which becomes sterically blocked. In contrast to most GPCRs, the actin cytoskeleton rather than ␤-arrestin seems to play an important role in physical separation of agonist-occupied FPRs from the signaling G-protein; such physical separation eventually terminates the signaling from the occupied FPRs (43, 63, 64) . The model for how the FPRs become desensitized is very similar to this general model, except for the involvement of actin rather than arrestin. Actin binding physically separates the receptor from the G-protein in the plane of the plasma membrane. Latrunculin A disrupts the cell cytoskeleton by binding to actin polymers and thus inhibiting their polymerization to F-actin fibers (65) . The effects of latrunculin A on the FPR1-mediated oxidase activity fully support this model. In agreement with the suggested role of the cytoskeleton in FPR1 termination/desensitization, neutrophils desensitized to the FPR1 agonist were also rapidly reactivated upon addition of the actin-binding drug. A model for Cmp1/FFA2R signaling based on the GPCR/cytoskeleton interaction concept of FPRs suggests that the nonoccupied FFA2R interacts more strongly with the cytoskeleton. A conformational change in the FFA2R induced by agonist binding leads to a G-protein-coupled signaling route, resulting in a rise in intracellular Ca 2ϩ ; provided that the cells have been primed, the NADPH oxidase is also activated. Disruption of the cytoskeleton with latrunculin A prior to agonist binding would also allow for the activated FFA2R to access the signaling route, leading to an activation of the oxidase, and the signals generated would then be comparable to FPR1, which is also what we found. However, in the presence of latrunculin A, superoxide production was turned off more rapidly when induced by Cmp1 than when induced by the FPR1 agonist. In fact, the FFA2R response in the presence of latrunculin A resembled that induced by FPR1 in the absence of latrunculin A; i.e., also in the presence of latrunculin A the cells had an intact system for the termination of the FFA2R-triggered response. The FPR/ cytoskeleton interaction model for termination of signaling is, thus, not directly applicable to the FFA2R response and suggests an alternative, non-cytoskeleton-dependent alternative mode that is shared by the ATP/P2Y 2 R ligand/receptor pair (66) . In accordance, the nonsignaling, desensitized FFA2Rs were not reactivated by a disruption of the cytoskeleton and the latrunculin A effect was lost very rapidly after receptor activation with Cmp1. We conclude that a non-cytoskeleton-dependent desensitization mechanism of FFA2R is put into action promptly after agonist binding, and we have previously shown that signaling by the neutrophil P2Y 2 R is turned off by a similar mechanism, whereas the FPRs depend on the cytoskeleton for desensitization and termination of signaling (66) .
We show that Cmp1 and CATPB function as an agonist and antagonist for the neutrophil FFA2R, respectively, and that the signals generated in neutrophils by the activated receptor triggered a secretion of superoxide anions, a response largely increased in TNF-␣-primed neutrophils, possibly involving a mobilization of receptors from the granules. Although the agonist-occupied FFA2R activates effector functions similar to those activated by FPRs, the regulatory mechanisms downstream of these receptors differ. The fact that the amplifying effect of a disruption of the cytoskeleton is much larger for signaling by FFA2R suggests that this receptor is partly blocked in naive cells, possibly through interaction of the cytosolic parts of the receptor with the actin cytoskeleton. Signaling by the Cmp1/FFA2R complex is also rapidly terminated by swift receptor desensitization, but the mechanism for how signaling is turned off differs from that of the FPRs. The fact that short-chain fatty acids are produced by gut microbes during anaerobic metabolism has suggested that receptors for such molecules expressed on innate immune cells are of prime importance for regulating inflammatory reactions in the gut (67) , but the fact that the tissue-recruited neutrophils were nonresponding to the FFA2R agonist suggests a role for the receptor also in other organs and that the role of FFA2Rs is complex and needs further analysis.
FIG 11 Cmp1-induced activation in exudated neutrophils is reduced. (A)
NADPH oxidase activity induced by fMIFL (1 nM) in peripheral blood neutrophils and exudated neutrophils. The release of superoxide anion was measured; curves from a representative experiment are shown together with the mean peak values obtained from two independent experiments (inset). The time point for addition of the agonist is indicated by an arrow. (B) The NADPH oxidase activity induced Cmp1 (2 M) in peripheral blood neutrophils and exudated neutrophils was assessed in the presence of latrunculin A (25 ng/ml). The release of superoxide anion was measured; curves from a representative experiment are shown together with the mean peak values obtained from two independent experiments (inset). The time point for addition of the agonist is indicated by an arrow.
